SpyGlass Pharma, Inc. (SGP)
Data as of , from SEC Form 4 filings.
See up to 3 months of SGP. The 7-day demo opens the 1M and 3M ranges and puts SGP on your watchlist.
Start 7-day demoLatest SGP insider trades
About SpyGlass Pharma, Inc. (SGP)
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
- IRVINE, CA
- 65
- 2026
- XNAS
SGP Form 4 activity by transaction type, last 90 days
No Form 4 activity for SGP in the last 90 days.
SGP insider transactions (Form 4)
16930 Form 4 filings on record, the earliest from Feb 9, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Other | Common Stock | 2,524,473 | - footnote F1 | - | |
| RA CAPITAL MANAGEMENT, L.P. | Other | Common Stock | 1,806,644 | - footnote F1 | - | |
| RA CAPITAL MANAGEMENT, L.P. | Open-market purchase | Common Stock | 3,441,966 | $16.00 | $55.07M | |
| RA CAPITAL MANAGEMENT, L.P. | Open-market purchase | Common Stock | 248,034 | $16.00 | $3.97M | |
| RA CAPITAL MANAGEMENT, L.P. | Other | Series C-1 Preferred Stock | 1,150,941 | - footnote F1 | - | |
| RA CAPITAL MANAGEMENT, L.P. | Other | Series C-1 Preferred Stock | 767,294 | - footnote F1 | - | |
| RA CAPITAL MANAGEMENT, L.P. | Other | Series C-2 Preferred Stock | 1,150,941 | - footnote F1 | - | |
| RA CAPITAL MANAGEMENT, L.P. | Other | Series C-2 Preferred Stock | 767,294 | - footnote F1 | - | |
| RA CAPITAL MANAGEMENT, L.P. | Other | Series D Preferred Stock | 222,591 | - footnote F1 | - | |
| RA CAPITAL MANAGEMENT, L.P. | Other | Series D Preferred Stock | 272,056 | - footnote F1 | - | |
| ||||||
| Kirk G. Nielsen | Other | Series B Preferred Stock | 1,690,230 | - | - | |
| Kirk G. Nielsen | Other | Series C-1 Preferred Stock | 548,067 | - | - | |
| Kirk G. Nielsen | Other | Series C-2 Preferred Stock | 548,067 | - | - | |
| Kirk G. Nielsen | Other | Series D Preferred Stock | 359,255 | - | - | |
 Ali Behbahani | Other | Common Stock | 1,619,240 | - footnote F1 | - | |
| Ali Behbahani | Other | Common Stock | 1,370,168 | - footnote F1 | - | |
| Ali Behbahani | Other | Common Stock | 1,370,168 | - footnote F1 | - | |
| Ali Behbahani | Other | Common Stock | 737,962 | - footnote F1 | - | |
| Ali Behbahani | Open-market purchase | Common Stock | 937,500 | $16.00 | $15.00M | |
| Ali Behbahani | Other | Common Stock | 954,990 | - footnote F1 | - | |
| Ali Behbahani | Other | Common Stock | 402,273 | - footnote F1 | - | |
| Ali Behbahani | Other | Series B Preferred Stock | 1,619,240 | - footnote F1 | - | |
| Ali Behbahani | Other | Series C-1 Preferred Stock | 1,370,168 | - footnote F1 | - | |
| Ali Behbahani | Other | Series C-2 Preferred Stock | 1,370,168 | - footnote F1 | - | |
| Ali Behbahani | Other | Series D Preferred Stock | 737,962 | - footnote F1 | - | |
| Ali Behbahani | Other | Series A Preferred Stock | 954,990 | - footnote F1 | - | |
| Ali Behbahani | Other | Series B Preferred Stock | 402,273 | - footnote F1 | - | |
| ||||||
| Anthony A. Florence Jr. | Other | Common Stock | 1,619,240 | - footnote F1 | - | |
| Anthony A. Florence Jr. | Open-market purchase | Common Stock | 937,500 | $16.00 | $15.00M | |
| Anthony A. Florence Jr. | Other | Common Stock | 954,990 | - footnote F1 | - | |
| Anthony A. Florence Jr. | Other | Common Stock | 402,273 | - footnote F1 | - | |
| Anthony A. Florence Jr. | Other | Series B Preferred Stock | 1,619,240 | - footnote F1 | - | |
| Anthony A. Florence Jr. | Other | Series C-1 Preferred Stock | 1,370,168 | - footnote F1 | - | |
| Anthony A. Florence Jr. | Other | Common Stock | 1,370,168 | - footnote F1 | - | |
| Anthony A. Florence Jr. | Other | Common Stock | 1,370,168 | - footnote F1 | - | |
| Anthony A. Florence Jr. | Other | Common Stock | 737,962 | - footnote F1 | - | |
| Anthony A. Florence Jr. | Other | Series C-2 Preferred Stock | 1,370,168 | - footnote F1 | - | |
| Anthony A. Florence Jr. | Other | Series D Preferred Stock | 737,962 | - footnote F1 | - | |
| Anthony A. Florence Jr. | Other | Series A Preferred Stock | 954,990 | - footnote F1 | - | |
| Anthony A. Florence Jr. | Other | Series B Preferred Stock | 402,273 | - footnote F1 | - | |
| ||||||
| Forest Baskett | Other | Common Stock | 1,370,168 | - footnote F1 | - | |
| Forest Baskett | Other | Common Stock | 1,619,240 | - footnote F1 | - | |
| Forest Baskett | Other | Common Stock | 1,370,168 | - footnote F1 | - | |
| Forest Baskett | Other | Common Stock | 737,962 | - footnote F1 | - | |
| Forest Baskett | Open-market purchase | Common Stock | 937,500 | $16.00 | $15.00M | |
| Forest Baskett | Other | Common Stock | 954,990 | - footnote F1 | - | |
| Forest Baskett | Other | Common Stock | 402,273 | - footnote F1 | - | |
| Forest Baskett | Other | Series B Preferred Stock | 1,619,240 | - footnote F1 | - | |
| Forest Baskett | Other | Series C-1 Preferred Stock | 1,370,168 | - footnote F1 | - | |
| Forest Baskett | Other | Series C-2 Preferred Stock | 1,370,168 | - footnote F1 | - | |
| Forest Baskett | Other | Series D Preferred Stock | 737,962 | - footnote F1 | - | |
| Forest Baskett | Other | Series A Preferred Stock | 954,990 | - footnote F1 | - | |
| Forest Baskett | Other | Series B Preferred Stock | 402,273 | - footnote F1 | - | |
| ||||||
| New Enterprise Associates 17, L.P. | Other | Common Stock | 1,619,240 | - footnote F1 | - | |
| New Enterprise Associates 17, L.P. | Other | Common Stock | 1,370,168 | - footnote F1 | - | |
| New Enterprise Associates 17, L.P. | Other | Common Stock | 1,370,168 | - footnote F1 | - | |
| New Enterprise Associates 17, L.P. | Other | Common Stock | 737,962 | - footnote F1 | - | |
| New Enterprise Associates 17, L.P. | Open-market purchase | Common Stock | 937,500 | $16.00 | $15.00M | |
| New Enterprise Associates 17, L.P. | Other | Series B Preferred Stock | 1,619,240 | - footnote F1 | - | |
| New Enterprise Associates 17, L.P. | Other | Series C-1 Preferred Stock | 1,370,168 | - footnote F1 | - | |
| New Enterprise Associates 17, L.P. | Other | Series C-2 Preferred Stock | 1,370,168 | - footnote F1 | - | |
| New Enterprise Associates 17, L.P. | Other | Series D Preferred Stock | 737,962 | - footnote F1 | - | |
| ||||||
 Rick Yang | Other | Common Stock | 1,619,240 | - footnote F1 | - | |
| Rick Yang | Other | Common Stock | 1,370,168 | - footnote F1 | - | |
| Rick Yang | Other | Common Stock | 1,370,168 | - footnote F1 | - | |
| Rick Yang | Other | Common Stock | 737,962 | - footnote F1 | - | |
| Rick Yang | Open-market purchase | Common Stock | 937,500 | $16.00 | $15.00M | |
| Rick Yang | Other | Series B Preferred Stock | 1,619,240 | - footnote F1 | - | |
| Rick Yang | Other | Series C-1 Preferred Stock | 1,370,168 | - footnote F1 | - | |
| Rick Yang | Other | Series C-2 Preferred Stock | 1,370,168 | - footnote F1 | - | |
| Rick Yang | Other | Series D Preferred Stock | 737,962 | - footnote F1 | - | |
| ||||||
| Mohamad Makhzoumi | Other | Common Stock | 1,619,240 | - footnote F1 | - | |
| Mohamad Makhzoumi | Other | Common Stock | 1,370,168 | - footnote F1 | - | |
| Mohamad Makhzoumi | Other | Common Stock | 1,370,168 | - footnote F1 | - | |
| Mohamad Makhzoumi | Other | Common Stock | 737,962 | - footnote F1 | - | |
| Mohamad Makhzoumi | Open-market purchase | Common Stock | 937,500 | $16.00 | $15.00M | |
| Mohamad Makhzoumi | Other | Common Stock | 954,990 | - footnote F1 | - | |
| Mohamad Makhzoumi | Other | Common Stock | 402,273 | - footnote F1 | - | |
| Mohamad Makhzoumi | Other | Series B Preferred Stock | 1,619,240 | - footnote F1 | - | |
| Mohamad Makhzoumi | Other | Series C-1 Preferred Stock | 1,370,168 | - footnote F1 | - | |
| Mohamad Makhzoumi | Other | Series C-2 Preferred Stock | 1,370,168 | - footnote F1 | - | |
| Mohamad Makhzoumi | Other | Series D Preferred Stock | 737,962 | - footnote F1 | - | |
| Mohamad Makhzoumi | Other | Series A Preferred Stock | 954,990 | - footnote F1 | - | |
| Mohamad Makhzoumi | Other | Series B Preferred Stock | 402,273 | - footnote F1 | - | |
| ||||||
 Scott D. Sandell | Other | Common Stock | 1,619,240 | - footnote F1 | - | |
| Scott D. Sandell | Other | Common Stock | 1,370,168 | - footnote F1 | - | |
| Scott D. Sandell | Other | Common Stock | 1,370,168 | - footnote F1 | - | |
| Scott D. Sandell | Other | Common Stock | 737,962 | - footnote F1 | - | |
| Scott D. Sandell | Open-market purchase | Common Stock | 937,500 | $16.00 | $15.00M | |
| Scott D. Sandell | Other | Common Stock | 954,990 | - footnote F1 | - | |
| Scott D. Sandell | Other | Common Stock | 402,273 | - footnote F1 | - | |
| Scott D. Sandell | Other | Series B Preferred Stock | 1,619,240 | - footnote F1 | - | |
| Scott D. Sandell | Other | Series C-1 Preferred Stock | 1,370,168 | - footnote F1 | - | |
| Scott D. Sandell | Other | Series C-2 Preferred Stock | 1,370,168 | - footnote F1 | - | |
| Scott D. Sandell | Other | Series D Preferred Stock | 737,962 | - footnote F1 | - | |
| Scott D. Sandell | Other | Series A Preferred Stock | 954,990 | - footnote F1 | - | |
| Scott D. Sandell | Other | Series B Preferred Stock | 402,273 | - footnote F1 | - | |
| ||||||
 Carmen Chang | Other | Common Stock | 737,962 | - footnote F1 | - | |
| Carmen Chang | Open-market purchase | Common Stock | 937,500 | $16.00 | $15.00M | |
| Carmen Chang | Other | Common Stock | 954,990 | - footnote F1 | - | |
| Carmen Chang | Other | Common Stock | 402,273 | - footnote F1 | - | |
| Carmen Chang | Other | Series B Preferred Stock | 1,619,240 | - footnote F1 | - | |
| Carmen Chang | Other | Series C-1 Preferred Stock | 1,370,168 | - footnote F1 | - | |
| Carmen Chang | Other | Series C-2 Preferred Stock | 1,370,168 | - footnote F1 | - | |
| Carmen Chang | Other | Common Stock | 1,619,240 | - footnote F1 | - | |
| Carmen Chang | Other | Common Stock | 1,370,168 | - footnote F1 | - | |
| Carmen Chang | Other | Common Stock | 1,370,168 | - footnote F1 | - | |
| Carmen Chang | Other | Series D Preferred Stock | 737,962 | - footnote F1 | - | |
| Carmen Chang | Other | Series A Preferred Stock | 954,990 | - footnote F1 | - | |
| Carmen Chang | Other | Series B Preferred Stock | 402,273 | - footnote F1 | - | |
| ||||||
 Paul Edward Walker | Other | Common Stock | 1,619,240 | - footnote F1 | - | |
| Paul Edward Walker | Other | Common Stock | 1,370,168 | - footnote F1 | - | |
| Paul Edward Walker | Other | Common Stock | 1,370,168 | - footnote F1 | - | |
| Paul Edward Walker | Other | Common Stock | 737,962 | - footnote F1 | - | |
| Paul Edward Walker | Open-market purchase | Common Stock | 937,500 | $16.00 | $15.00M | |
| Paul Edward Walker | Other | Common Stock | 954,990 | - footnote F1 | - | |
| Paul Edward Walker | Other | Common Stock | 402,273 | - footnote F1 | - | |
| Paul Edward Walker | Other | Series B Preferred Stock | 1,619,240 | - footnote F1 | - | |
| Paul Edward Walker | Other | Series C-1 Preferred Stock | 1,370,168 | - footnote F1 | - | |
| Paul Edward Walker | Other | Series C-2 Preferred Stock | 1,370,168 | - footnote F1 | - | |
| Paul Edward Walker | Other | Series D Preferred Stock | 737,962 | - footnote F1 | - | |
| Paul Edward Walker | Other | Series A Preferred Stock | 954,990 | - footnote F1 | - | |
| Paul Edward Walker | Other | Series B Preferred Stock | 402,273 | - footnote F1 | - | |
| ||||||
| Edward T. Mathers | Other | Common Stock | 1,619,240 | - footnote F1 | - | |
| Edward T. Mathers | Other | Common Stock | 1,370,168 | - footnote F1 | - | |
| Edward T. Mathers | Other | Common Stock | 1,370,168 | - footnote F1 | - | |
| Edward T. Mathers | Other | Common Stock | 737,962 | - footnote F1 | - | |
| Edward T. Mathers | Open-market purchase | Common Stock | 937,500 | $16.00 | $15.00M | |
| Edward T. Mathers | Other | Series B Preferred Stock | 1,619,240 | - footnote F1 | - | |
| Edward T. Mathers | Other | Series C-1 Preferred Stock | 1,370,168 | - footnote F1 | - | |
| Edward T. Mathers | Other | Series C-2 Preferred Stock | 1,370,168 | - footnote F1 | - | |
| Edward T. Mathers | Other | Series D Preferred Stock | 737,962 | - footnote F1 | - | |
| ||||||
| Geoffrey B. Pardo | Other | Common Stock | 1,875,013 | $0.00 footnote F1 | - | |
| Geoffrey B. Pardo | Open-market purchase | Common Stock | 312,500 | $16.00 | $5.00M | |
| Geoffrey B. Pardo | Other | Series D Preferred Stock | 1,875,013 | - footnote F1 | - | |
| ||||||
| Bilal Arshad Khan | Open-market purchase | Common Stock | 20,000 | $16.00 | $320K | |
| Bilal Arshad Khan | Open-market purchase | Common Stock | 115,000 | $16.00 | $1.84M | |
| Kirk G. Nielsen | Other | Common Stock | 1,690,230 | - footnote F1 | - | |
| Kirk G. Nielsen | Open-market purchase | Common Stock | 165,000 | $16.00 | $2.64M | |
| Kirk G. Nielsen | Other | Common Stock | 548,067 | - footnote F1 | - | |
| Kirk G. Nielsen | Other | Common Stock | 548,067 | - footnote F1 | - | |
| Kirk G. Nielsen | Other | Common Stock | 359,255 | - footnote F1 | - | |
| Kirk G. Nielsen | Other | Series B Preferred Stock | 9,689,922 | - footnote F1 | - | |
| Kirk G. Nielsen | Other | Series C-1 Preferred Stock | 3,142,015 | - footnote F1 | - | |
| Kirk G. Nielsen | Other | Series C-2 Preferred Stock | 3,142,015 | - footnote F1 | - | |
| Kirk G. Nielsen | Other | Series D Preferred Stock | 2,059,573 | - footnote F1 | - | |
| ||||||
| Vensana Capital I GP, LLC | Other | Common Stock | 1,690,230 | - footnote F1 | - | |
| Vensana Capital I GP, LLC | Other | Common Stock | 548,067 | - footnote F1 | - | |
| Vensana Capital I GP, LLC | Other | Common Stock | 548,067 | - footnote F1 | - | |
| Vensana Capital I GP, LLC | Other | Common Stock | 359,255 | - footnote F1 | - | |
| Vensana Capital I GP, LLC | Open-market purchase | Common Stock | 165,000 | $16.00 | $2.64M | |
| Vensana Capital I GP, LLC | Other | Series B Preferred Stock | 9,689,922 | - footnote F1 | - | |
| Vensana Capital I GP, LLC | Other | Series C-1 Preferred Stock | 3,142,015 | - footnote F1 | - | |
| Vensana Capital I GP, LLC | Other | Series C-2 Preferred Stock | 3,142,015 | - footnote F1 | - | |
| Vensana Capital I GP, LLC | Other | Series D Preferred Stock | 2,059,573 | - footnote F1 | - | |
| ||||||
| RA CAPITAL MANAGEMENT, L.P. | Grant or award | Stock Option (right to buy) | 27,400 | $0.00 | - | |
| Ali Behbahani | Grant or award | Stock Option (right to buy) | 27,400 | $0.00 | - | |
| Kirk G. Nielsen | Grant or award | Stock Option (right to buy) | 27,400 | $0.00 | - | |
| Zachary Scheiner | Grant or award | Stock Option (right to buy) | 27,400 | $0.00 | - | |
| Bilal Arshad Khan | Grant or award | Stock Option (right to buy) | 13,700 | $0.00 | - | |
| Habib J. Dable | Grant or award | Stock Option (right to buy) | 27,400 | $0.00 | - | |
| Geoffrey B. Pardo | Grant or award | Stock Option (right to buy) | 27,400 | $0.00 | - | |
| Michael Dybbs | Grant or award | Stock Option (right to buy) | 27,400 | $0.00 | - | |
| Elizabeth G. O'Farrell | Grant or award | Stock Option (right to buy) | 13,700 | $0.00 | - | |
| James Robert Dennewill Jr. - Officer | Grant or award | Stock Option (right to buy) | 105,000 | $0.00 | - | |
| Chetan Pratap Pujara - Officer | Grant or award | Stock Option (right to buy) | 105,000 | $0.00 | - | |
| Malik Y. Kahook - Officer | Grant or award | Stock Option (right to buy) | 105,000 | $0.00 | - | |
| Jean-Frederic Viret - Officer | Grant or award | Stock Option (right to buy) | 17,500 | $0.00 | - | |
| Patrick H. Mooney - Officer | Grant or award | Stock Option (right to buy) | 300,000 | $0.00 | - | |
Item 7.01, 8.01, 9.01
Item 2.02, 9.01
Item 2.02, 9.01
Item 2.02, 9.01
SGP insider trading FAQ
What is the latest insider trade for SGP?
SpyGlass Pharma, Inc. (SGP) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-02-11. The full record for SGP runs to 30 Form 4 filings, the earliest from 2026-02-09. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying SGP stock?
No insider purchases of SGP were filed in the last 90 days. 17 purchases are on record for this company.
How many insiders are selling SGP stock?
No insider sales of SGP were filed in the last 90 days.
Where can I see SGP SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects SGP Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - RA CAPITAL MANAGEMENT, L.P. view on EDGAR
- - Kirk G. Nielsen view on EDGAR
- - Ali Behbahani view on EDGAR
- - Anthony A. Florence Jr. view on EDGAR
- - Forest Baskett view on EDGAR
- - New Enterprise Associates 17, L.P. view on EDGAR
- - Rick Yang view on EDGAR
- - Mohamad Makhzoumi view on EDGAR
- - Scott D. Sandell view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where SGP's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow SGP with a 7-day demo
- SGP on your watchlist
- Every SGP Form 4 filing on record
- Up to 3 months of SGP price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
